Download Sample
Add to CartGlobal Veterinary Or Animal Vaccines Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Livestock Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines and Aquaculture Vaccines.By Technology;
Live Attenuated Vaccine, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Veterinary Or Animal Vaccines Market (USD Million), 2021 - 2031
In the year 2024, the Global Veterinary Or Animal Vaccines Market was valued at USD 11,171.40 million. The size of this market is expected to increase to USD 17,246.41 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.
The global veterinary or animal vaccines market has witnessed significant growth over the past few years. This growth is driven by the increasing incidence of zoonotic diseases, rising awareness about animal health, and the expansion of the livestock and companion animal populations. Additionally, technological advancements in vaccine development and the growing emphasis on preventive care are contributing to the market's expansion. The market encompasses a variety of vaccines, including those for livestock, poultry, companion animals, aquaculture, and other animals, catering to both prophylactic and therapeutic needs.
Several factors are propelling the growth of the veterinary vaccines market. One of the primary drivers is the heightened focus on food safety and the increasing demand for high-quality animal-derived food products. This necessitates the health and well-being of livestock, thus fueling the demand for effective vaccines. Furthermore, the surge in pet ownership globally has increased the demand for companion animal vaccines. Innovations in biotechnology, such as recombinant DNA technology and gene-deleted vaccines, are also driving market growth by providing more effective and safer vaccination options.
The market's growth dynamics vary significantly across different regions. North America and Europe currently hold the largest market shares, driven by high animal healthcare expenditures, advanced veterinary infrastructure, and robust R&D activities. Meanwhile, the Asia-Pacific region is expected to witness the highest growth rate due to the rising livestock population, increasing awareness about animal health, and supportive government initiatives. In emerging markets, the expansion of the veterinary vaccines market is further supported by economic growth and urbanization, which boost both livestock production and pet adoption rates.
Global Veterinary Or Animal Vaccines Market Recent Developments
- In September 2022, Merck Animal Health launched NobivacIntra-Trac Oral BbPi for the dual prevention of two major canine respiratory pathogens.
- In August 2022, the Indian Council of Agricultural Research, ICAR-National Research Centre on Equines (ICAR-NRCE), Hisar (Haryana), in collaboration with ICAR-Indian Veterinary Research Institute (IVRI), Uttar Pradesh developed a homologous live-attenuated Lumpy Skin Disease vaccine named Lumpi-ProVacInd.
Segment Analysis
The global veterinary vaccines market is segmented based on product type into several categories including live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, and conjugate vaccines. Live attenuated vaccines, which contain a version of the living microbe that has been weakened in the lab so it can't cause disease, are widely used due to their effectiveness in inducing a strong and lasting immune response. Inactivated vaccines, containing killed pathogens, are favored for their safety profile, especially in immunocompromised animals. Subunit and toxoid vaccines, which include only parts of the pathogen or inactivated toxins, respectively, are tailored for specific pathogens and often used where precise immunity is required. Conjugate vaccines, combining weak antigens with strong ones, are gaining traction for their ability to enhance immune response in younger or older animals.
The market is also divided based on the type of animals into livestock animals and companion animals. Livestock animals include cattle, poultry, swine, and sheep, among others. Vaccines for livestock animals dominate the market due to the high economic importance of preventing diseases in these populations to ensure food security and economic stability. Companion animals, such as dogs, cats, and horses, form a significant and growing segment driven by the increasing pet ownership and the humanization of pets. This segment is witnessing robust growth owing to rising awareness about pet health, an increase in preventive healthcare expenditure by pet owners, and the expanding portfolio of vaccines available for a range of companion animal diseases.
Geographically, the veterinary vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America leads the market owing to its advanced veterinary healthcare infrastructure, high adoption rate of new veterinary vaccines, and robust R&D activities. Europe follows closely, driven by strong regulatory frameworks and significant government initiatives supporting animal health. The Asia Pacific region is expected to exhibit the highest growth rate over the forecast period due to increasing livestock population, rising pet adoption, and improving veterinary healthcare services. Latin America and Middle East & Africa are also showing promising growth potential with increasing awareness about animal health and burgeoning investments in veterinary infrastructure.
Global Veterinary Or Animal Vaccines Segment Analysis
In this report, the global veterinary or animal vaccines market has been segmented by type, technology and geography.
Global Veterinary Or Animal Vaccines Market, Segmentation by Type
The Global Veterinary Or Animal Vaccines Market has been segmented by Type into Livestock Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines and Aquaculture Vaccines.
The global veterinary or animal vaccines market is segmented into several types, reflecting the diverse needs and challenges in animal healthcare. One major segment is based on the type of animal being vaccinated, including livestock, companion animals, poultry, and aquatic animals. Livestock vaccines, such as those for cattle, sheep, and pigs, are crucial for preventing economically devastating diseases like foot-and-mouth disease, bovine respiratory disease, and swine flu. Companion animal vaccines, including those for dogs, cats, and horses, focus on preventing common diseases such as rabies, distemper, and equine influenza, ensuring the health of pets and animals in close contact with humans.
Another significant segmentation within the market is by vaccine technology. This includes live attenuated vaccines, inactivated vaccines, toxoid vaccines, conjugate vaccines, and recombinant vaccines. Live attenuated vaccines contain weakened forms of the pathogen, offering strong and long-lasting immunity, but with a slight risk of causing disease in immunocompromised animals. Inactivated vaccines, made from killed pathogens, are safer but may require booster shots to maintain immunity. Toxoid vaccines target the toxins produced by pathogens rather than the pathogen itself, while conjugate and recombinant vaccines represent advanced biotechnological approaches to enhance the immune response and safety profile.
The market can be segmented by the method of administration. Common methods include injectable vaccines, oral vaccines, and intranasal vaccines. Injectable vaccines are the most prevalent due to their effectiveness and established administration protocols. Oral vaccines offer the advantage of ease of administration and are particularly useful in large-scale livestock farming. Intranasal vaccines provide an alternative route that can stimulate local immunity in the respiratory tract, beneficial for respiratory pathogens. Each method has its own set of advantages and challenges, influencing their adoption based on the specific needs of animal health management.
Global Veterinary Or Animal Vaccines Market, Segmentation by Technology
The Global Veterinary Or Animal Vaccines Market has been segmented by Technology into Live Attenuated Vaccine, Inactivated Vaccines, Recombinant Vaccines and Toxoid Vaccines.
The global veterinary or animal vaccines market is characterized by a variety of technological approaches, each catering to specific needs within animal health. One prominent segment is the inactivated or killed vaccines, which involve pathogens that have been killed or inactivated so they cannot cause disease. These vaccines are known for their safety, as the inactivated pathogens cannot revert to a virulent form. They typically require multiple doses to achieve and maintain immunity but are widely used for their reliability and the broad spectrum of immune responses they can elicit. This technology is especially beneficial for diseases where the risk of live pathogen reversion is a concern, ensuring a safe immunization process for livestock and companion animals alike.
Another critical segment within this market is the live attenuated vaccines, which use live pathogens that have been weakened under laboratory conditions so they cannot cause disease in healthy animals. These vaccines tend to elicit a strong and long-lasting immune response with fewer doses compared to inactivated vaccines. Live attenuated vaccines often mimic natural infection closely, leading to comprehensive immunity. However, there is a slight risk that the attenuated pathogens could revert to a more virulent form, which necessitates careful monitoring and handling. Despite this, their effectiveness in creating robust immunity makes them indispensable in veterinary medicine, particularly in controlling diseases that require swift and sustained immune responses.
Recombinant vaccines represent another advanced segment, employing genetic engineering techniques to induce immunity. These vaccines can include subunit vaccines, where only essential antigens of the pathogen are used, or vector vaccines, where genes encoding pathogen antigens are inserted into a benign virus or bacterium to provoke an immune response. Recombinant vaccines offer high specificity and safety, as they avoid the use of live pathogens altogether. They also facilitate the development of vaccines for complex diseases and can be tailored to induce strong and targeted immune responses. This technology is paving the way for next-generation vaccines that are not only safer but also highly effective, addressing the evolving needs of animal health care in a rapidly changing global landscape.
Global Veterinary Or Animal Vaccines Market, Segmentation by Geography
In this report, the Global Veterinary Or Animal Vaccines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Veterinary Or Animal Vaccines Market Share (%), by Geographical Region, 2024
The global veterinary or animal vaccines market exhibits a diverse landscape across different geographical regions. In North America, the market is characterized by advanced veterinary healthcare infrastructure and significant investments in research and development. The presence of key market players and a high adoption rate of advanced veterinary vaccines contribute to the region's dominance. Moreover, stringent regulations regarding animal health and welfare further bolster market growth in this region.
In Europe, the veterinary vaccines market is driven by increasing awareness regarding zoonotic diseases and the growing demand for livestock products. Additionally, favorable government initiatives aimed at controlling animal diseases and promoting vaccination campaigns support market expansion. The presence of established pharmaceutical companies specializing in animal health also contributes to the region's market growth.
In the Asia Pacific region, the veterinary vaccines market is witnessing rapid growth due to factors such as rising pet adoption, increasing livestock production, and growing concerns about food safety. Emerging economies like China and India are experiencing a surge in demand for veterinary vaccines driven by urbanization, rising disposable income, and a growing focus on animal health management. Furthermore, government initiatives to control the spread of diseases among animals and improve agricultural productivity are fueling market growth in this region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Veterinary Or Animal Vaccines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Pet Ownership
- Rising Incidence of Zoonotic Diseases
-
Advancements in Vaccine Technology - Advancements in vaccine technology have significantly transformed the global veterinary or animal vaccines market, enhancing both the efficacy and scope of immunization efforts. One of the notable innovations is the development of recombinant DNA vaccines, which utilize genetically engineered DNA to produce specific antigens that trigger an immune response. These vaccines are highly specific, ensuring that the immune system targets the exact pathogens without the risk of causing disease, making them safer and more effective compared to traditional vaccines. Moreover, the use of adjuvants, substances that enhance the body's immune response to an antigen, has been refined. Modern adjuvants boost the effectiveness of vaccines, enabling lower doses to achieve the desired immunity, thereby reducing costs and minimizing potential side effects.
Another key advancement is the rise of nanoparticle-based vaccines. These vaccines use nanoparticles to deliver antigens more efficiently to the immune system, providing controlled release and targeted delivery, which enhances the immune response and ensures prolonged protection. Additionally, advancements in vaccine delivery methods, such as needle-free injection systems and oral vaccines, have improved the ease of administration and compliance, particularly in large-scale livestock operations. This has made vaccination campaigns more feasible and effective, especially in developing regions where traditional methods may be challenging. These technological advancements not only improve animal health and productivity but also contribute to better public health by reducing the transmission of zoonotic diseases.
Restraints:
- High Cost of Vaccine Development
- Stringent Regulatory Approvals
-
Limited Awareness in Emerging Markets - The global veterinary or animal vaccines market faces significant challenges in emerging markets, primarily due to limited awareness among livestock and pet owners. Many farmers and animal caretakers in these regions lack sufficient knowledge about the benefits of vaccinating animals, leading to lower adoption rates of vaccines. This gap in awareness can be attributed to inadequate education and training programs, insufficient dissemination of information by veterinary health services, and cultural practices that may not prioritize preventive healthcare for animals. Consequently, diseases that could be prevented through vaccination continue to affect animal populations, impacting animal health and productivity, and ultimately posing risks to human health through zoonotic diseases.
The infrastructural challenges in emerging markets exacerbate the issue of limited awareness. Veterinary services in these regions often suffer from a lack of resources, such as vaccines, cold chain logistics, and skilled veterinary professionals. This scarcity hinders effective vaccination campaigns and limits the reach of educational initiatives aimed at promoting the benefits of animal vaccination. The combination of these factors results in a slower uptake of vaccination practices, thereby hampering the overall growth of the veterinary vaccines market in these regions. Addressing these challenges requires concerted efforts to improve veterinary infrastructure, enhance training programs for animal health workers, and implement widespread awareness campaigns to educate animal owners about the importance of vaccines.
Opportunities:
- Expansion in Emerging Markets
- Development of Novel Vaccines
-
Public-Private Partnerships - Public-private partnerships play a pivotal role in the global veterinary and animal vaccines market by leveraging the strengths of both sectors to enhance research and development. Governments and private entities collaborate to address the high costs and risks associated with vaccine development. Public institutions provide funding, regulatory support, and access to research facilities, while private companies contribute with innovation, advanced technology, and expertise in large-scale production and distribution. This synergy facilitates the development of new vaccines, ensuring they reach the market efficiently and are available to a broader range of livestock and pet populations. Such collaborations are crucial in tackling emerging animal diseases, ensuring food security, and safeguarding public health by preventing zoonotic diseases.
These partnerships also drive global initiatives for disease control and eradication, particularly in regions with limited resources. International organizations, such as the World Organisation for Animal Health (OIE) and the Food and Agriculture Organization (FAO), often play a coordinating role, bringing together stakeholders from various countries and sectors. By pooling resources and knowledge, these collaborations enhance the capacity for rapid response to outbreaks, improve surveillance systems, and ensure the sustainable supply of essential vaccines. Additionally, they support capacity-building efforts in developing countries, helping to strengthen veterinary infrastructure and improve overall animal health standards. Through such cooperative efforts, public-private partnerships are instrumental in advancing the global veterinary and animal vaccines market, contributing to the health and well-being of animals and humans alike.
Competitive Landscape Analysis
Key players in Global Veterinary Or Animal Vaccines Market include:
- Zoetis Inc.
- Merck Animal Health (a division of Merck & Co., Inc.)
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Virbac
- Phibro Animal Health Corporation
- Heska Corporation
- Indian Immunologicals Ltd.
- Biogenesis Bago
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Technology
- Market Snapshot, By Region
- Global Veterinary/Animal Vaccines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Pet Ownership
- Rising Incidence of Zoonotic Diseases
- Advancements in Vaccine Technology
- Restraints
- High Cost of Vaccine Development
- Stringent Regulatory Approvals
- Limited Awareness in Emerging Markets
- Opportunities
- Expansion in Emerging Markets
- Development of Novel Vaccines
- Public-Private Partnerships
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Compititive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Veterinary/Animal Vaccines Market, By Type, 2021 - 2031 (USD Million)
- Livestock Vaccines
- Porcine Vaccines
- Companion Animal Vaccines
- Poultry Vaccines
- Aquaculture Vaccines
- Global Veterinary/Animal Vaccines Market, By Technology, 2021 - 2031 (USD Million)
- Live Attenuated Vaccine
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Global Veterinary/Animal Vaccines Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Veterinary/Animal Vaccines Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Zoetis Inc.
- Merck Animal Health (a division of Merck & Co., Inc.)
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Virbac
- Phibro Animal Health Corporation
- Heska Corporation
- Indian Immunologicals Ltd.
- Biogenesis Bago
- Company Profiles
- Analyst Views
- Future Outlook of the Market